Goldman Sachs’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.2K | Buy |
|
|||||
|
2025
Q1 | $38K | Buy |
|
|||||
|
2024
Q4 | $46K | Sell |
|
|||||
|
2024
Q3 | $71.5K | Buy |
|
|||||
|
2024
Q2 | $47.5K | Hold |
|
|||||
|
2024
Q1 | $42.5K | Hold |
|
|||||
|
2023
Q4 | $19.8K | Hold |
|
|||||
|
2023
Q3 | $21K | Hold |
|
|||||
|
2023
Q2 | $20.9K | Sell |
|
|||||
|
2023
Q1 | $12K | Sell |
|
|||||
|
2022
Q4 | $51.8K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $100K | Sell |
|
|||||
|
2021
Q4 | $233K | Buy |
|
|||||
|
2021
Q3 | $79K | Buy |
|